Cover Image
市場調查報告書

全球新興醫療設備技術市場

Global Markets for Emerging Medical Device Technologies

出版商 BCC Research 商品編碼 372636
出版日期 內容資訊 英文 306 Pages
訂單完成後即時交付
價格
Back to Top
全球新興醫療設備技術市場 Global Markets for Emerging Medical Device Technologies
出版日期: 2016年09月30日 內容資訊: 英文 306 Pages
簡介

全球新興醫療設備技術市場預計從2016年的559億美元到2021年達到980億美元。2016∼2021年的年複合成長率預計為10.2%。

本報告提供全球新興醫療設備技術市場相關調查,市場概要與趨勢,至2021年的預測,產業趨勢,市場機會,及產業的主要參與企業簡介彙整。

第1章 簡介

第2章 摘要

第3章 心血管市場上新興設備技術

  • 心血管設備
  • 標的疾病與經濟負擔
  • 心臟衰竭的新興設備技術
  • 市售及研究開發平台的設備技術
  • 電生理學的新興設備技術
  • 介入性心臟學的新興設備技術
  • 血管內動脈瘤/主動脈修復的新興設備技術
  • 置入式除顫器的新興設備技術
  • 末梢血管設備的新興設備技術
  • 經導管心臟瓣膜的振興技術

第4章 整形外科市場上新興設備技術

  • 整形外科市場
  • 標的疾病與適應
  • 新興整形外科設備技術
  • 軟組織固定及修復的新興設備技術

第5章 神經市場上新興設備技術

  • 神經血管裝置
  • 新興技術
  • 新興神經調節設備技術

第6章 糖尿病護理市場上的新興設備技術

  • 糖尿病的照護設備
  • 糖尿病管理上的新興技術
  • 糖尿病的流行病學
  • 胰島素幫浦的整合
  • 競爭環境
  • 其他新興設備技術

第7章 體外診斷市場上新興診斷技術

  • 神經調節診斷
  • 新興癌症分子和搭配診斷
  • 照護現場診斷

第8章 無針頭藥物輸送技術

  • 無針藥物輸送技術
  • 已上市及研究開發平台產品
  • 研究開發平台產品

第9章 腸胃內視鏡中的新興設備技術

第10章 其他技術

第11章 法律規章結構

第12章 定價與給付

第13章 結論:新興醫療設備技術預測

第14章 企業簡介

圖表

目錄
Product Code: HLC191A

REPORT HIGHLIGHTS

The global market for emerging medical device technologies should reach $90.8 billion by 2021 from $55.9 billion in 2016 at a compound annual growth rate (CAGR) of 10.2%, from 2016 to 2021.

This report provides:

  • An overview of the global markets for emerging medical device technologies.
  • Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021.
  • Evaluation of the market's dynamics, specifically growth drivers, inhibitors, and opportunities.
  • Analyses of segments within the overall market including: aesthetics/dermatology, cardiovascular, dental, diabetes care, gastroenterology, nephrology, urology, gynecology/women's health, medical imaging/visualization, in-vitro diagnostics, neurology, ophthalmology, orthopedic, drug delivery/pain management, surgical/wound care and patient management/monitoring.
  • An in depth look at growth driving factors such as the rising prevalence of chronic diseases and related increase in disability-adjusted life years, technological advancements in medical devices, and the growing aging population
  • Product analysis detailing key marketed and pipeline devices
  • Profiles of major players in the field

REPORT SCOPE

Traditional medical devices include devices (e.g., metallic stents, heart valves, open procedures, general instruments, non-drug coated implantables, large endoscopes, needle based drug delivery, lab based diagnostics etc.) that have been in use over the last two to three decades for the treatment and management of various diseases. Emerging medical device technologies include devices and technologies (e.g., bioresorbable implants, coated implants and balloons, transcatheter heart valves (TAVR, TMVR), electrophysiology, S-ICDs, cardioMEMS, wireless monitoring, wearable devices, needle-free drug delivery, capsule endoscopes, POC tests, companion diagnostics, etc.), which are relatively new (in practice over the last two to 10 years), advanced and have better outcomes in the treatment and management of world's deadly and chronic diseases. This report is an analytical business tool whose primary purpose is to describe the thorough evaluation of the global market for emerging medical device technologies. The format of the study is organized around the following topics:

  • Detailed study around emerging medical device technologies within general surgery, cardiovascular, diabetes care, gastroenterology, medical imaging/visualization, in vitro diagnostics, neurology, ophthalmology, orthopedic, drug delivery/pain management, surgical/wound care and patient monitoring.
  • Target disease demographics and cost burden.
  • Regulatory structure.
  • Market characterization, unmet need, market size and segmentation.
  • Market drivers and restraints.
  • Detailed market projections through 2021.
  • Competition and market shares.
  • Pricing and reimbursement.
  • Marketed and pipeline (R&D) products along with descriptions, regulatory status and clinical trials.
  • Observations and conclusions regarding the future of medical device technologies.
  • Profiles of market participants and associations.

ANALYST'S CREDENTIALS

Dr. Ritu Thakur, author of this report, is an independent consultant based in New Delhi, India. She has prior work experience with Panasonic (Healthcare Division) and GlobalData (U.K.-based market research firm). In her previous assignments she has written many reports on pharmaceutical, medical and biotechnology subjects. She has developed reports for BCC Research for four years and has worked as an author for healthcare and other related industries such as pharmaceuticals and medical devices.

Table of Contents

CHAPTER 1 - INTRODUCTION

  • MEDICAL TECHNOLOGY
  • STUDY BACKGROUND
  • STUDY GOALS AND OBJECTIVES
  • INTENDED AUDIENCE
  • SCOPE OF THE REPORT
  • METHODOLOGY AND INFORMATION SOURCES
  • ANALYST'S CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 - SUMMARY

  • EXECUTIVE SUMMARY
    • CARDIOVASCULAR
    • ORTHOPEDIC
    • NEUROLOGY
    • DIABETES CARE
    • IN VITRO DIAGNOSTICS
    • GI AND ENDOSCOPY
    • OPHTHALMICS
    • WOUND CARE MANAGEMENT
    • DRUG DELIVERY
      • SUMMARY TABLE: GLOBAL MARKET FOR EMERGING MEDICAL DEVICE TECHNOLOGIES, BY SEGMENT, THROUGH 2021 ($ MILLIONS)
      • SUMMARY FIGURE: GLOBAL MARKET FOR EMERGING MEDICAL DEVICE TECHNOLOGIES, BY SEGMENT, 2015-2021 ($ MILLIONS)

CHAPTER 3 - EMERGING DEVICE TECHNOLOGIES IN CARDIOVASCULAR MARKET

  • CARDIOVASCULAR DEVICES
  • TARGET DISEASES AND ECONOMIC BURDEN
    • ANGINA PECTORIS
      • TABLE 1: GLOBAL PREVALENCE OF ANGINA PECTORIS AND STROKE (SURVIVORS), THROUGH 2030 (THOUSANDS)
    • STROKE
      • TABLE 2: GLOBAL INCIDENCE OF STROKE AND CONGESTIVE HEART FAILURE, THROUGH 2030 (THOUSANDS)
    • HYPERTENSION
      • FIGURE 1: HYPERTENSION EPIDEMIOLOGY, BY PATIENT GROUP, 2015 (% OF TOTAL PATIENTS)
    • MORTALITY RATES
      • TABLE 3: GLOBAL DEATHS, BY CARDIOVASCULAR DISEASE, THROUGH 2030 (THOUSANDS)
      • FIGURE 2: DISTRIBUTION OF GLOBAL DEATHS, BY CARDIOVASCULAR DISEASE, 2015 (% OF TOTAL DEATHS DUE TO CARDIOVASCULAR DISEASES)
  • EMERGING DEVICE TECHNOLOGIES FOR HEART FAILURE
    • HEART FAILURE DEVICES
      • Cardiac Resynchronization Therapy (CRT) Devices
      • Ventricular Assist Device (VAD)
      • Wireless Heart Failure Sensor (CardioMEMS)
  • MARKET SIZE AND GROWTH ANALYSIS
    • TABLE 4: GLOBAL MARKET FOR EMERGING HEART FAILURE DEVICE TECHNOLOGIES, BY REGION, THROUGH 2021 ($ MILLIONS)
    • FIGURE 3: GLOBAL MARKET SHARES FOR EMERGING HEART FAILURE DEVICE TECHNOLOGIES, BY REGION, 2015 (%)
    • TABLE 5: GLOBAL MARKET FOR EMERGING HEART FAILURE DEVICE TECHNOLOGIES, BY TYPE, 2015 ($ MILLIONS)
    • FIGURE 4: GLOBAL MARKET SHARES OF EMERGING HEART FAILURE DEVICE TECHNOLOGIES, BY TYPE, 2015 (%)
    • Market Growth Drivers and Restraints
  • KEY MARKETED AND R&D PIPELINE DEVICE TECHNOLOGIES
    • Recently FDA Approved Device Technologies
      • CardioMEMS HF System (P100045A)
      • CONTAK CD CRT-D System (P010012)
    • R&D Pipeline Device Technologies
      • Symphony Heart Pump (from Abiomed)
      • Impella Pediatric Pump (from Abiomed)
      • Abiocor II (from Abiomed)
      • Impella CP Next Generation Emergency Heart Pump (from Abiomed)
      • Revivent-TC Ventricular Enhancement System (from BioVentrix)
      • MiniVAD (from Calon Cardio-Technology)
      • CathVAD (from Calon Cardio-Technology)
      • Hotor (from Coras Medical)
      • Endotronix Care Management Solution (from Endotronix)
      • ClearView Measurement System (from EPIC Research & Diagnostics)
        • TABLE 6: R &D PIPELINE DEVICE TECHNOLOGIES FOR HEART FAILURE
      • MiFlow VAD (from HeartWare)
      • SYNERGY Pocket Circulatory Assist Device (from HeartWare)
      • HW005 Ventricular Assist System (from HeartWare)
      • New Mitroflow (from LivaNova)
      • Platinium (Brady & Tachy) (from LivaNova)
      • Paradym CRT-D Tri-V (from LivaNova)
      • Symplicity Renal Denervation System (from Medtronic)
      • Chronicle ICD (from Medtronic)
      • MediGuide Enabled CRT (from Medtronic)
      • Chronicle IHM (from Medtronic)
      • Hemodynamic Monitor (from Retia Medical)
      • HeartPOD (from St. Jude Medical)
      • Promote LAP System (from St. Jude Medical)
      • Apica VAD Surgical Implant System SIS (from St. Jude Medical)
      • Vixiar Device (from Vixiar Medical)
    • STRATEGIC DEALS (KEY MERGERS AND ACQUISITIONS)
      • TABLE 7: RECENT KEY STRATEGIC DEALS IN HEART FAILURE DEVICES TECHNOLOGIES, 2013-2015
  • EMERGING DEVICE TECHNOLOGIES FOR ELECTROPHYSIOLOGY (EP)
    • ELECTROPHYSIOLOGY (EP)
    • MARKET SIZE AND GROWTH ANALYSIS
      • TABLE 8: GLOBAL MARKET FOR ELECTROPHYSIOLOGY DEVICE TECHNOLOGIES, BY REGION, THROUGH 2021 ($ MILLIONS)
      • FIGURE 5: GLOBAL MARKET SHARES OF ELECTROPHYSIOLOGY DEVICE TECHNOLOGIES, BY REGION, 2015 (%)
      • TABLE 9: GLOBAL MARKET FOR ELECTROPHYSIOLOGY DEVICE TECHNOLOGIES, BY TYPE, 2015 ($ MILLIONS)
      • FIGURE 6: GLOBAL MARKET SHARES OF ELECTROPHYSIOLOGY DEVICE TECHNOLOGIES, BY TYPE, 2015 (%)
      • TABLE 10: GLOBAL MARKET FOR ELECTROPHYSIOLOGY, BY TYPE, 2015 ($ MILLIONS)
      • FIGURE 7: GLOBAL MARKET SHARES OF ELECTROPHYSIOLOGY, BY TYPE, 2015 (%)
      • Market Growth Drivers and Restraints
    • KEY MARKETED AND R&D PIPELINE PRODUCTS
      • Recently FDA Approved Device Technologies
        • WATCHMAN LAA Closure Technology (P130013) (from Boston Scientific)
      • R&D Pipeline Device Technologies
        • Atrial Fibrillation Technology (from Actuated Medical)
        • CoolLoop (from Afreeze)
        • Next Generation Integrated Platform (from Apama Medical)
        • AtriCure Bipolar System (from AtriCure)
        • IntellaNav XP and IntellaNav MiFi OL (from Boston Scientific)
        • Artisan Control AF Catheter (from Hansen Medical)
        • Lambre LAA Occluder (from Lifetech Scientific)
        • Voyager Irrigated RF Ablation Catheter and Sheath System (from MicroPort Scientific)
        • VeriSense Ablation and EnSite HD Grid Catheter Mapping System (from St. Jude Medical)
          • TABLE 11: KEY R &D PIPELINE DEVICE TECHNOLOGIES IN ELECTROPHYSIOLOGY
    • STRATEGIC DEALS (KEY MERGERS AND ACQUISITIONS)
      • TABLE 12: RECENT KEY STRATEGIC DEALS IN ELECTROPHYSIOLOGY
  • EMERGING DEVICE TECHNOLOGIES FOR INTERVENTIONAL CARDIOLOGY
    • INTERVENTIONAL CARDIOLOGY
      • Rapid Exchange PTCA Catheter
      • Intravascular Ultrasound Systems (IVUS)
      • Bioresorbable Vascular Scaffolds (BVS)
    • MARKET SIZE AND GROWTH ANALYSIS
      • TABLE 13: GLOBAL MARKET FOR INTERVENTIONAL CARDIOLOGY DEVICE TECHNOLOGIES, BY REGION, THROUGH 2021 ($ MILLIONS)
      • FIGURE 8: GLOBAL MARKET SHARES OF INTERVENTIONAL CARDIOLOGY DEVICE TECHNOLOGIES, BY REGION, 2015 (%)
      • TABLE 14: GLOBAL MARKET FOR INTERVENTIONAL CARDIOLOGY DEVICE TECHNOLOGIES, BY TYPE, 2015 ($ MILLIONS)
      • FIGURE 9: GLOBAL MARKET SHARES OF INTERVENTIONAL CARDIOLOGY DEVICE TECHNOLOGIES, BY TYPE, 2015 (%)
      • Market Growth Drivers and Restraints
    • KEY MARKETED AND R&D PIPELINE DEVICE TECHNOLOGIES
      • Recently FDA Approved Device Technologies
      • Absorb GT1 BVS System (P150023) (from Abbott)
      • R&D Pipeline Device Technologies
        • Stanza Bioresorbable (from 480 Biomedical)
        • Esprit Drug-Eluting BVS (from Abbott Laboratories)
        • Adient Medical Totally Absorbable Vascular Filter (from Adient Medical)
        • APTITUDE (120-micron) Bioresorbable Drug-Eluting Coronary Scaffold (from Amaranth Medical)
        • EmboMedics Resorbable Microspheres (from AngioDynamics)
        • BioBelle Bioabsorbable Cardiac Matrix (from Bellerophon Therapeutics)
        • DREAMS 2nd Generation (from BIOTRONIK)
        • Fully Resorbable Drug-Eluting Scaffold System (from Boston Scientific)
        • CINATRA ISA 247 Coated Coronary Stent System (from Getinge)
        • MGuard Coronary Plus Bio-Absorbable Drug-Eluting Mesh (from InspireMD)
        • Firefalcon Bioresorbable (from MicroPort Scientific)
        • MicroPort Firesorb Bioresorbable Rapamycin Target Eluting Coronary Scaffold (from MicroPort Scientific)
        • ReZolve2 Sirolimus-Eluting Bioresorbable Coronary Scaffold (from REVA Medical)
        • Fantom Bioresorbable Scaffold (from REVA Medical)
          • TABLE 15: KEY R &D PIPELINE DEVICE TECHNOLOGIES FOR BIORESORBABLE VASCULAR SCAFFOLD (BVS)
    • STRATEGIC DEALS (KEY MERGERS AND ACQUISITIONS)
      • TABLE 16: RECENT KEY STRATEGIC DEALS FOR INTERVENTIONAL CARDIOLOGY, 2012-2015
  • EMERGING DEVICE TECHNOLOGIES FOR ENDOVASCULAR ANEURYSM/AORTIC REPAIR (EVAR)
    • AORTIC ANEURYSM (ABDOMINAL AND THORASIC)
    • ENDOVASCULAR REPAIR OF AORTIC ANEURYSMS
      • TABLE 17: EPIDEMIOLOGY OF AAA AND TAA
    • AAA AND TAA STENT GRAFTS
      • TABLE 18: GLOBAL NUMBER OF AORTIC ANEURYSM REPAIR PROCEDURES, BY PROCEDURE TYPE, 2015 (NO.)
    • SHIFT FROM OPEN TO EVAR
      • FIGURE 10: U.S. AAA PROCEDURES, BY SURGERY TYPE, 2015 (%)
    • MARKET SIZE AND GROWTH ANALYSIS
      • TABLE 19: GLOBAL MARKET FOR EVAR AND TEVAR, BY REGION, THROUGH 2021 ($ MILLIONS)
      • FIGURE 11: GLOBAL MARKET SHARES OF EVAR AND TEVAR, BY REGION, 2015-2021 (%)
      • TABLE 20: GLOBAL MARKET OF EVAR AND TEVAR, BY ANEURYSM TYPE, 2015 ($ MILLIONS)
      • FIGURE 12: GLOBAL MARKET SHARES FOR EVAR AND TEVAR, BY ANEURYSM TYPE, 2015 (%)
      • Market Growth Drivers and Restraints
    • KEY MARKETED AND R&D PIPELINE DEVICE TECHNOLOGIES
      • FDA Approved Device Technologies
        • Endologix PowerLink System (P040002) (from Endologix)
        • Zenith AAA Endovascular Graft and the H&L-B One-Shot Introduction System (P020018) (from Cook)
        • Endurant Stent Graft System (P100021) (from Medtronic)
      • Key R&D Pipeline Device Technologies
        • Ventana Fenestrated Stent Graft System (from Endologix)
        • Xpand (from Endologix)
        • AFX3 Endovascular AAA System (from Endologix)
        • VELA2 Proximal Endograft System (from Endologix)
        • Nellix w/Snorkels (from Endologix)
        • Paravisceral System (from Endologix)
        • Nellix ChEVAS (from Endologix)
        • Ovation Alto System (from Endologix)
        • NEXUS (from Endospan)
        • HORIZON AAA Repair (from Endospan)
        • Ankura Branched/Fenestrated Stent Graft (from Lifetech Scientific)
        • Thoracic Stent-Graft (from Lombard Medical Technologies)
        • IntelliFlex LP Delivery System (from Lombard Medical Technologies)
        • Valiant Mona LSA System (from Medtronic)
        • Endurant Evo AAA Stent Graft (from Medtronic)
        • Valiant Evo (from Medtronic)
        • TAAA Debranching Stent Graft Endovascular Stent (from Medtronic)
        • Valiant TAAA Stent Graft System (from Medtronic)
        • Ultra-Low Profile AAA Stent-Graft System (from MicroPort Scientific)
        • Thoraflex (from Terumo)
        • Tumbao EndoVascular Aortic Repair System (from Transcatheter Technologies)
    • GORE EXCLUDER Conformable AAA Endoprosthesis (from W. L. Gore)
      • TABLE 21: KEY R &D PIPELINE DEVICE TECHNOLOGIES FOR ENDOVASCULAR AORTIC REPAIR
    • STRATEGIC DEAL: ENDOLOGIX ACQUIRED TRIVASCULAR TECHNOLOGIES
    • COMPETITION IN EVAR SEGMENT
  • EMERGING DEVICE TECHNOLOGIES FOR IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD)
    • CONVENTIONAL ICD
    • SUBCUTANEOUS ICD (S-ICD)
    • MARKET SIZE AND GROWTH ANALYSIS FOR SUBCUTANEOUS ICD
      • TABLE 22: GLOBAL MARKET FOR S-ICD, THROUGH 2021 ($ MILLIONS)
      • Market Growth Drivers and Restraints
    • KEY MARKETED AND PIPELINE DEVICE TECHNOLOGIES
      • TABLE 23: RECENTLY FDA APPROVED S-ICD DEVICE TECHNOLOGIES
  • EMERGING DEVICE TECHNOLOGIES FOR PERIPHERAL VASCULAR DEVICES
    • PERIPHERAL VASCULAR DEVICES
      • Atherectomy
        • Synthetic Surgical Grafts
      • Drug-Coated Balloons (DCB)
    • MARKET SIZE AND GROWTH ANALYSIS
      • TABLE 24: GLOBAL MARKET FOR PERIPHERAL VASCULAR DEVICE TECHNOLOGIES, BY REGION, THROUGH 2021 ($ MILLIONS)
      • FIGURE 13: GLOBAL MARKET SHARES OF PERIPHERAL VASCULAR DEVICE TECHNOLOGIES, BY REGION, 2015 (%)
      • TABLE 25: GLOBAL MARKET FOR PERIPHERAL VASCULAR DEVICE TECHNOLOGIES, BY TYPE, 2015 ($ MILLIONS)
      • FIGURE 14: GLOBAL MARKET SHARES OF PERIPHERAL VASCULAR DEVICE TECHNOLOGIES, BY TYPE, 2015 (%)
      • Market Growth Drivers and Restraints
    • KEY MARKETED AND PIPELINE DEVICE TECHNOLOGIES
      • Recently FDA Approved Device Technologies
        • Misago Peripheral Stent System (P140002) (Terumo)
        • Protege GPS Self-Expanding Peripheral Stent System (P060001/S020) (ev3)
      • Key R&D Pipeline Device Technologies
        • Callisyn Peripheral Microcatheter (from Callisyn Biomedical)
        • MGuard Peripheral Plus Bio-Stable Mesh (from InspireMD)
        • Next-Generation Drug-Coated Balloon with Kinesyx Technology (from Interface Biologics)
        • Reewarm PTX Drug Balloon Dilation Catheter (from MicroPort Scientific)
        • Reewarm18 Peripheral Balloon Dilation Catheter (from MicroPort Scientific)c
        • Drug-Coated Balloon (from Elixir Medical)
        • Thermal Sensing System (from Accumed Systems)
        • NG PROMUS Stent System (from Boston Scientific)
        • Diamondback 360 Coronary Micro Crown Orbital Atherectomy System (from Cardiovascular Systems)
        • SESAME Stent (from Palmaz Scientific)
        • Innova Peripheral Vascular Drug-Eluting Stent (from Boston Scientific)
          • TABLE 26: KEY R &D PIPELINE DEVICE TECHNOLOGIES FOR PERIPHERAL VASCULAR MARKET
    • STRATEGIC DEALS (KEY MERGERS AND ACQUISITIONS)
      • TABLE 27: RECENT KEY STRATEGIC DEALS FOR PERIPHERAL VASCULAR DEVICE TECHNOLOGIES, 2012-2015
  • EMERGING TECHNOLOGIES FOR TRANSCATHETER HEART VALVE TECHNOLOGIES
    • TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR)
    • TRANSCATHETER MITRAL VALVE REPLACEMENT (TMVR)
    • MARKET SIZE AND GROWTH ANALYSIS
      • TABLE 28: GLOBAL MARKET FOR TRANSCATHETER HEART VALVE TECHNOLOGIES, BY REGION, THROUGH 2021 ($ MILLIONS)
      • FIGURE 15: GLOBAL MARKET SHARES OF TRANSCATHETER HEART VALVE TECHNOLOGIES, BY REGION, 2015 (%)
      • Market Growth Drivers and Restraints
    • KEY MARKETED AND PIPELINE DEVICE TECHNOLOGIES
      • Recently FDA Approved Device Technologies
        • Melody Transcatheter Pulmonary Valve (P140017) (from Medtronic)
        • Medtronic CoreValve System (P130021/S010) (from Medtronic)
        • Edwards SAPIEN 3 Transcatheter Heart Valve (P140031) (from Edwards Lifesciences)
      • R&D Pipeline Device Technologies
        • Tendyne Transcatheter Mitral Valve Implant (from Abbott)
        • BIOVALVE Prosthesis (from BIOTRONIK)
        • HLT Transcatheter Valve System (from Bracco)
        • Mitra-Spacer (from Cardiosolutions)
        • Colibri Aortic Heart Valve (from Colibri Heart Valve)
        • Delta Aortic Heart Valve (from Colibri Heart Valve)
        • Mitramaze Valve Repair System (from Coramaze Technologies)
        • CENTERA Transcatheter Heart Valve and ZETA Surgical Valve (from Edwards Lifesciences)
        • FORTIS Transcatheter Mitral Heart Valve (from Edwards Lifesciences)
        • CardiAQ's 2nd Generation Transcatheter Mitral Valve (from Edwards Lifesciences)
        • SAPIEN 3 (from Edwards Lifesciences)
        • Beating Heart Mitral Valve Repair (from Harpoon Medical)
        • JenaValve System (Transfemoral) (from JenaValve Technology)
        • Embolic Deflection Device (from Keystone Heart)
        • Perceval S Sutureless Aortic Valve (from LivaNova)
        • Mitra-Spacer (from LivaNova)
        • HighLife Transcatheter Mitral Valve (from LivaNova)
        • Caisson Mitral Replacement System (from LivaNova)
        • Model 400 Aortic Valve Bioprosthesis (from Medtronic)
        • Twelve Transcatheter Mitral Valve Replacement System (from Medtronic)
        • Harmony Transcatheter Pulmonary Valve (from Medtronic)
        • CoreValve Evolut 34R System (from Medtronic)
        • enCorTC (from MiCardia)
        • MitrAssist (from MitrAssist)
        • Tiara (from Neovasc)
        • AngioScore Valvuloplasty Scoring Balloon (from Spectranetics)
        • TAVI Systems (from Symetis)
        • Trinity TAVI System (from Transcatheter Technologies)
        • Tresillo Mitral Valve Implantation System (from Transcatheter Technologies)
          • TABLE 29: KEY R &D PIPELINE DEVICE TECHNOLOGIES FOR TRANSCATHETER HEART VALVE MARKET
    • STRATEGIC DEALS (KEY MERGERS AND ACQUISITIONS)
      • TABLE 30: RECENT KEY STRATEGIC DEALS FOR TRANSCATHETER HEART VALVE MARKET, 2010-2016
    • COMPETITIVE LANDSCAPE IN EMERGING CARDIOVASCULAR DEVICE TECHNOLOGIES MARKET
      • TABLE 31: GLOBAL MARKET FOR EMERGING CARDIOVASCULAR DEVICE TECHNOLOGIES, BY LEADING COMPANIES, 2015 ($ MILLIONS)
      • FIGURE 16: GLOBAL MARKET SHARES OF LEADING COMPANIES IN EMERGING CARDIOVASCULAR DEVICE TECHNOLOGIES, 2016 (%)
  • OTHER CARDIOVASCULAR EMERGING DEVICES TECHNOLOGIES
    • WEARABLE CARDIOVERTER DEFIBRILLATOR
    • MINI HEART PUMP (IMPELLA RP SYSTEM (H140001) FROM ABIOMED)
    • SUTURELESS MYOCARDIAL PACING LEADS
    • TRANSCATHETER PACEMAKER SYSTEM
    • ALGISYL-LVR MINIMALLY INVASIVE (FROM LONESTAR HEART)
    • HOTOR (FROM CORAS MEDICAL)
    • TUBRIDGE PARENT ARTERY RECONSTRUCTION DEVICE (FROM MICROPORT SCIENTIFIC)
    • PENUMBRA LIBERTY STENT SYSTEM (FROM PENUMBRA)

CHAPTER 4 - EMERGING DEVICE TECHNOLOGIES IN ORTHOPEDIC MARKET

  • ORTHOPEDIC MARKET
  • TARGET DISEASES AND INDICATIONS
    • EPIDEMIOLOGY OF MUSCULOSKELETAL DISORDERS
      • Osteoarthritis
      • Rheumatoid Arthritis
      • Osteoporosis
      • Gout (Gouty Arthritis)
      • Back and Neck Pain
        • TABLE 32: GLOBAL SYMPTOMATIC PREVALENCE OF KEY MUSCULOSKELETAL DISORDERS, BY TYPE, THROUGH 2021 (THOUSANDS)
        • FIGURE 17: DISTRIBUTION OF GLOBAL SYMPTOMATIC PREVALENCE OF KEY MUSCULOSKELETAL DISORDERS, BY REGION, 2015 (THOUSANDS)
    • MORTALITY RATES OF MUSCULOSKELETAL DISEASES
      • TABLE 33: GLOBAL DEATHS, BY MUSCULOSKELETAL DISORDER, THROUGH 2030 (NO.)
      • FIGURE 18: DISTRIBUTION OF GLOBAL DEATHS, BY MUSCULOSKELETAL DISORDER, 2015 (% OF TOTAL DEATHS DUE TO MUSCULOSKELETAL DISORDERS)
  • EMERGING ORTHOPEDIC DEVICE TECHNOLOGIES
  • EMERGING DEVICE TECHNOLOGIES FOR EXTREMITY JOINT RECONSTRUCTION (EXCLUDING HIP AND KNEE)
    • SHOULDER RECONSTRUCTION AND REPLACEMENT
    • SMALL JOINTS RECONSTRUCTION AND REPLACEMENT
      • Foot and Ankle
      • Hand and Wrist
      • Elbow
      • Digits
    • MARKET SIZE AND GROWTH ANALYSIS
      • TABLE 34: GLOBAL EXTREMITY JOINT RECONSTRUCTION PROCEDURES, BY TYPE, THROUGH 2021 (NO.)
      • TABLE 35: GLOBAL MARKET FOR EXTREMITY JOINT RECONSTRUCTION DEVICE TECHNOLOGIES, BY REGION, THROUGH 2021 ($ MILLIONS)
      • FIGURE 19: GLOBAL MARKET SHARES OF EXTREMITY JOINT RECONSTRUCTION DEVICE TECHNOLOGIES, BY REGION, 2015 (%)
      • TABLE 36: GLOBAL MARKET FOR EXTREMITY JOINT RECONSTRUCTION DEVICE TECHNOLOGIES, BY TYPE, 2015 ($ MILLIONS)
      • FIGURE 20: GLOBAL MARKET SHARES OF EXTREMITY JOINT RECONSTRUCTION DEVICE TECHNOLOGIES, BY TYPE, 2015 (%)
      • TABLE 37: GLOBAL MARKET FOR SMALL JOINT RECONSTRUCTION DEVICE TECHNOLOGIES, BY TYPE, 2015 ($ MILLIONS)
      • FIGURE 21: GLOBAL MARKET SHARES OF SMALL JOINT RECONSTRUCTION DEVICE TECHNOLOGIES, BY TYPE, 2015 (%)
      • Market Growth Drivers and Restraints
    • KEY MARKETED AND PIPELINE PRODUCTS
      • Recently FDA Approved Device Technologies
        • Arthrex PIP Dart (from Arthrex)
        • Infinity Total Ankle System (from Wright Medical)
        • ToeTac Hammertoe Fixation System (from Restore Surgical)
        • Simpliciti Ultra Short Stem Total Shoulder Arthroplasty (from Wright Medical)
        • Aequalis Perform+ Shoulder System (from Tornier)
        • Fibulock Nail (from Sonoma Orthopedic Products Inc.)
        • Initial R Distal Radius Kit (from Newclip Technics)
        • Proxifuse Hammertoe Correction System (from Cartiva Inc.)
          • TABLE 38: RECENTLY APPROVED DEVICE TECHNOLOGIES FOR EXTREMITY JOINT RECONSTRUCTION AND REPLACEMENT
      • R&D Pipeline Device Technologies
        • Arxis (from Audax Medical)
        • Advanced Shoulder Options (from Integra LifeSciences)
        • Akilos Total Ankle System (from Implants International)
        • 2-Piece Total Ankle Replacement (from Integra LifeSciences)
        • Augment Injectable Bone Graft (from Wright Medical Group)
        • Augment Chronic Tendinopathy (from Wright Medical Group)
        • Invision Revision Ankle System (from Wright Medical)
        • Salvation External Fixation System (from Wright Medical)
        • InSpace Balloon System (Orthospace Ltd.)
        • Cartiva Synthetic Cartilage Implant (from Cartiva Inc.)
          • TABLE 39: KEY R &D PIPELINE DEVICE TECHNOLOGIES FOR EXTREMITY JOINT RECONSTRUCTION
    • REIMBURSEMENT
  • EMERGING DEVICE TECHNOLOGIES FOR SOFT TISSUE FIXATION AND REPAIR
    • MARKET SIZE AND GROWTH ANALYSIS
      • TABLE 40: GLOBAL MARKET FOR SOFT TISSUE FIXATION AND REPAIR DEVICE TECHNOLOGIES, BY REGION, THROUGH 2021 ($ MILLIONS)
      • FIGURE 22: GLOBAL MARKET SHARES OF SOFT TISSUE FIXATION AND REPAIR DEVICE TECHNOLOGIES, BY REGION, 2015 (%)
      • TABLE 41: GLOBAL MARKET FOR SOFT TISSUE FIXATION AND REPAIR DEVICE TECHNOLOGIES, BY TYPE, 2015 ($ MILLIONS)
      • FIGURE 23: GLOBAL MARKET SHARES OF SOFT TISSUE FIXATION AND REPAIR DEVICE TECHNOLOGIES, BY TYPE, 2015 (%)
      • Market Growth Drivers and Restraints
    • KEY MARKETED AND R&D PIPELINE PRODUCTS
      • Recently FDA Approved Device Technologies
        • Univers Apex Subscapularis Repair Suture Kit (from Arthrex Inc.)
        • Q-Fix All-Suture Anchor (from Smith & Nephew)
        • SutureFIX Ultra Soft Anchor (from Smith & Nephew)
          • TABLE 42: RECENTLY APPROVED DEVICE TECHNOLOGIES FOR SOFT TISSUE FIXATION AND REPAIR
      • R&D Pipeline Device Technologies
        • A3T01 (from Aegeria Soft Tissue)
        • Scaffolds for Artificial Cartilage Development (from Bio-Scaffold International)
        • F2A Peptide (from BioSurface Engineering Technologies)
        • REPAIR Bone Putty (from Carmell Therapeutics)
        • DiscCell (from Gentis)
        • L-C Ligament (from Soft Tissue Regeneration)
        • Tissue Regeneration Systems (from Tissue Regeneration Systems)
        • dCELL Meniscus (from Tissue Regenix Group)
        • Z-Lig Xenograft (Aperion Biologics Corp.)
          • TABLE 43: KEY R &D PIPELINE DEVICE TECHNOLOGIES FOR SOFT TISSUE FIXATION AND REPAIR
    • REIMBURSEMENT
  • OTHER EMERGING ORTHOPEDIC DEVICE TECHNOLOGIES
    • SUPERION INTERSPINOUS SPACER (P140004) (VERTIFLEX)
    • ACTIVL ARTIFICIAL DISC (P120024) (AESCULAP IMPLANT SYSTEMS)
    • RADIESSE INJECTABLE IMPLANT (P050052/S049) (MERZ NORTH AMERICA)
    • RESTYLANE LYFT WITH LIDOCAINE INJECTABLE GEL INJECTABLE DERMAL FILLER (P040024/S073) (GALDERMA LABORATORIES)
    • COMPETITIVE LANDSCAPE IN EMERGING ORTHOPEDIC DEVICE TECHNOLOGIES MARKET
      • TABLE 44: LEADING COMPANIES IN THE GLOBAL MARKET FOR EMERGING ORTHOPEDIC DEVICE TECHNOLOGIES, 2015 ($ MILLIONS)
      • FIGURE 24: GLOBAL MARKET SHARES OF LEADING COMPANIES IN EMERGING CARDIOVASCULAR DEVICE TECHNOLOGIES, 2015 (%)

CHAPTER 5 - EMERGING DEVICE TECHNOLOGIES IN NEUROLOGY MARKET

  • NEUROVASCULAR DEVICES
    • TABLE 45: TARGET DEVICE TECHNOLOGIES FOR KEY DISEASE INDICATIONS
  • EMERGING NEUROVASCULAR DEVICE TECHNOLOGIES
    • CEREBRAL THROMBECTOMY DEVICES
    • FLOW DIVERTER FOR ANEURYSM
    • CAROTID ARTERY STENTING (CAS) SYSTEM
    • MARKET SIZE AND GROWTH ANALYSIS
      • TABLE 46 :GLOBAL MARKET FOR NEUROVASCULAR DEVICE TECHNOLOGIES, BY REGION, THROUGH 2021 ($ MILLIONS)
      • FIGURE 25: GLOBAL MARKET SHARES OF NEUROVASCULAR DEVICE TECHNOLOGIES, BY REGION, 2015 (%)
      • TABLE 47: GLOBAL MARKET FOR NEUROVASCULAR DEVICE TECHNOLOGIES, BY TYPE, 2015 ($ MILLIONS)
      • FIGURE 26: GLOBAL MARKET SHARES OF NEUROVASCULAR DEVICE TECHNOLOGIES, BY TYPE, 2015 (%)
      • FIGURE 27: GLOBAL MARKET SHARES OF CEREBRAL ANEURYSM DEVICE TECHNOLOGIES, BY TYPE, 2015 (%)
    • KEY MARKETED AND PIPELINE PRODUCTS
      • Recently FDA Approved Device Technologies
        • Senza SCS System (P130022) (Nevro Corp.)
        • Pipeline Embolization Device and Pipeline Flex (from Medtronic)
        • ENROUTE Transcarotid Stent System
        • The Solitaire 2 Revascularization Device
        • Trevo Retriever (from Stryker)
          • TABLE 48: RECENTLY APPROVED DEVICE TECHNOLOGIES FOR NEUROVASCULAR MARKET
      • R&D Pipeline Device Technologies
        • Surpass NeuroEndoGraft Flow Diverter (from Stryker)
        • ENTERPRISE Vascular Reconstruction Device (from J&J)
          • TABLE 49: KEY R &D PIPELINE DEVICE TECHNOLOGIES FOR NEUROVASCULAR MARKET
        • CoilControl 3D (from CVTec Cerebrovascular Technologies)
        • Gaudi Vascular Zippered Catheter (from Gaudi Vascular)
        • Gaudi Vascular Customized Stents (from Gaudi Vascular)
        • Gaudi Vascular Branched Stents (from Gaudi Vascular)
        • NVGuard Neurovascular (from InspireMD)
        • Shape Memory Polymer - Cerebral Aneurysm (from Shape Memory Therapeutics)
        • tDCS Accessories (from Soterix Medical)
    • STRATEGIC DEALS (KEY MERGERS AND ACQUISITIONS)
      • Bionik Laboratories acquired Interactive Motion Technologies
      • Stryker acquired Valenat/Synergetics USA's Neuro Portfolio
      • Medtronic acquired Medina
      • Integra Lifesciences acquired Covidien's Confluent Surgical Products
      • Covidien acquired Nfocus Neuromedical
      • Stryker acquired Surpass Medical
      • Stryker Acquired Concentric Medical
      • Covidien Acquired EV3
      • Stryker Acquired Neurovascular Product Line from Boston Scientific
      • Johnson & Johnson acquired Micrus Endovascular
        • TABLE 50: RECENT KEY STRATEGIC DEALS FOR NEUROVASCULAR MARKET, 2010-2016
    • COMPETITIVE LANDSCAPE IN THE NEUROVASCULAR MARKET
      • TABLE 51: GLOBAL MARKET FOR NEUROVASCULAR DEVICE TECHNOLOGIES, BY LEADING COMPANIES, 2015 ($ MILLIONS)
      • FIGURE 28 GLOBAL MARKET SHARES OF NEUROVASCULAR DEVICE TECHNOLOGIES, BY LEADING COMPANIES, 2015 (%)
    • NEUROMODULATION DEVICES
      • TABLE 52: NEUROMODULATION DEVICES AND TARGET DISEASE INDICATIONS
  • EMERGING NEUROMODULATION DEVICE TECHNOLOGIES
    • CEREBRAL THROMBECTOMY DEVICES
    • FLOW DIVERTER FOR ANEURYSM
    • CAROTID ARTERY STENTING (CAS) SYSTEM
    • MARKET SIZE AND GROWTH ANALYSIS
      • TABLE 53: GLOBAL MARKET FOR NEUROMODULATION DEVICE TECHNOLOGIES, BY REGION, 2015-2021 ($ MILLIONS)
      • FIGURE 29: GLOBAL MARKET SHARES OF NEUROMODULATION DEVICE TECHNOLOGIES, BY REGION, 2015 (%)
      • TABLE 54: GLOBAL MARKET FOR NEUROMODULATION DEVICE TECHNOLOGIES, BY TYPE, 2015 ($ MILLIONS)
      • FIGURE 30: GLOBAL MARKET SHARES OF NEUROMODULATION DEVICE TECHNOLOGIES, BY TYPE, 2015 (%)
    • KEY MARKETED AND PIPELINE PRODUCTS
      • Recently FDA Approved Device Technologies
        • Brio Neurostimulation System (P140009) (from St. Jude Medical)
        • Algovita Spinal Cord Stimulation System (P130028) (from Nuvectra Corp.)
        • Nevro Senza SCS System (P130022) (from Nevro Corp.)
        • Medtronic Interstim Sacral Nerve Stimulation Therapy System (P080025) (from Medtronic)
          • TABLE 55: KEY NEUROMODULATION PRODUCT BRANDS FROM LEADING PLAYERS
          • TABLE 56: RECENTLY APPROVED DEVICE TECHNOLOGIES FOR NEUROMODULATION MARKET
        • Medtronic's Enterra Neurostimulator
      • R&D Pipeline Device Technologies
        • StimRouter Neuromodulation System (from Bioness)
        • Bioness Battery Powered Microstimulator (from Bioness)
        • Vagal Nerve Stimulation (from Boston Scientific)
        • Multi-coil Transcranial Magnetic Stimulator (from Cervel Neurotech)
        • Life-Tech, Iontophor PM Deluxe Constant Current Stimulator (from Lifetech Scientific)
        • PrimeAdvanced Neurostimulator [Heart Failure] (from Medtronic)
        • SureStim-1 Implant (from Medtronic)
        • Serenity System (from MicroTransponder)
        • External Spinal Cord Neuromodulation System, Implantable Spinal Cord Neuromodulation System (from NeuroRecovery Technologies)
        • SetPoint Vagus Nerve Stimulator (from SetPoint Medical)
        • MOBILE Neuromodulation (from Soterix Medical)
        • Low Field Magnetic Stimulation (LFMS) Device (from Tal Medical)
          • TABLE 57: KEY R &D PIPELINE DEVICE TECHNOLOGIES FOR NEUROMODULATION MARKET
    • STRATEGIC DEALS (KEY MERGERS AND ACQUISITIONS)
      • Theragen Acquired Neurotech
      • St Jude Medical Acquired Spinal Modulation
      • Orthofix International Acquired an Option to Acquire eNeura
      • Cyberonics Acquired Sorin
      • Medtronic Acquired Advanced Uro-Solutions
      • St. Jude Medical Acquired NeuroTherm
      • Sorin Acquired Neurotech
      • Greatbatch Acquired NeuroNexus Technologies
      • Boston Scientific Acquired Intelect Medical
        • TABLE 58: RECENT KEY STRATEGIC DEALS FOR NEUROMODULATION MARKET
    • COMPETITIVE LANDSCAPE IN NEUROMODULATION
      • TABLE 59: GLOBAL MARKET FOR NEUROMODULATION DEVICES AND TECHNOLOGIES, BY LEADING COMPANIES, 2015 ($ MILLIONS)
      • FIGURE 31: GLOBAL MARKET SHARES OF NEUROMODULATION DEVICES AND TECHNOLOGIES, BY LEADING COMPANIES, 2015 (%)
    • OTHER NEUROMODULATION DEVICE TECHNOLOGIES
      • Directional DBS Lead (from St. Jude Medical)
      • Sentinel (from NeuroMetrix)
      • SurroGait Rx and Running Monitor (from Orpyx Medical Technologies)
      • Relay (from LivaNova)
      • Centro and CentroSR Generator (from LivaNova)
      • PhoenixRF SR and PhoenixRF NP (from LivaNova)
      • Cyberonics Accelerometer Device (from LivaNova)
      • SureSuite (from Medtronic)
      • Micropulse PNS Systems (from Medtronic)
    • OTHER EMERGING NEUROLOGY DEVICE TECHNOLOGIES
      • NOVUS SYSTEM (FROM BIONESS)
      • BMSEED MICROELECTRODE ARRAY (FROM BMSEED)
      • 1X1 LIMITED TOTAL ENERGY TDCS (FROM ELECTRICAL GEODESICS)
      • ILLUMINA 3D NEURAL TARGETING SOFTWARE (FROM ILLUMINA)
        • Neuro-Spinal Scaffold (from InVivo Therapeutics)
        • Bioengineered Neural Tissue (from InVivo Therapeutics)
        • ProGuardian (from LivaNova)
        • Vivistim System (from MicroTransponder)
        • Neural Regeneration Product (from NanoNerve)
        • Soterix Mobile and HD-tDCS Software (from Soterix Medical)
        • SCS MRI Platform (from St. Jude Medical)

CHAPTER 6 - EMERGING DEVICE TECHNOLOGIES IN DIABETES CARE MARKET

  • DIABETES CARE DEVICES
  • EMERGING TECHNOLOGIES IN DIABETES MANAGEMENT
    • CONTINUOUS GLUCOSE MONITORING SYSTEMS (CGMS)
    • INSULIN PUMP
      • Traditional Insulin Pumps
      • Disposable Insulin Pumps
  • EPIDEMIOLOGY OF DIABETES
    • TYPE 1 DIABETES
    • TYPE 2 DIABETES
      • TABLE 60: GLOBAL PREVALENCE OF DIABETES, THROUGH 2040 ($ MILLIONS)
    • MARKET SIZE AND GROWTH ANALYSIS
      • TABLE 61: GLOBAL MARKET FOR CGMS AND INSULIN PUMPS, BY REGION, THROUGH 2021 ($ MILLIONS)
      • FIGURE 32: GLOBAL MARKET SHARES OF CGMS AND INSULIN PUMPS, BY REGION, 2015 (%)
      • TABLE 62: GLOBAL MARKET FOR CGM SYSTEMS AND INSULIN PUMP, BY TYPE, 2015 ($ MILLIONS)
      • FIGURE 33: GLOBAL MARKET SHARES OF CGM SYSTEMS AND INSULIN PUMP, BY TYPE, 2015 (%)
      • Market Growth Drivers and Restraints
  • INSULIN PUMP INTEGRATION WITH CGM SYSTEMS
    • KEY MARKETED AND PIPELINE PRODUCTS
      • Recently FDA Approved Diagnostics
        • Dexcom G4 PLATINUM (Pediatric) Continuous Glucose
        • Monitoring System (P120005/S031) (Dexcom)
      • R&D Pipeline Device Technologies
        • Enlite 3 (from Medtronic)
        • Libre Sensor (from Abbott)
        • T1D Management System (from Bigfoot Biomedical)
        • Next-Generation CGM Products (from DexCom)
        • GlySens ICGM System (from GlySens)
        • Patch Delivery System (from Medtronic)
      • MiniMed 670G (from Medtronic)
        • GlucoMen Day (from Menarini)
        • Eversense CGM System (from Senseonics)
          • TABLE 63: KEY R &D PIPELINE DEVICES FOR CGM SYSTEMS
        • Artificial Pancreas (from Bigfoot Biomedical)
        • ONETOUCH Ping Verio Insulin Pump with Meter Remote (from Johnson & Johnson)
        • MiniMed 620G Insulin Pump (from Medtronic)
        • Predictive Low Glucose Management Technology (PLGM) (from Medtronic)
        • t:sport Insulin Delivery System (from Tandem Diabetes Care)
        • Imperium (from Unilife)
          • TABLE 64: KEY R &D PIPELINE DEVICES FOR INSULIN PUMPS
    • STRATEGIC DEALS (KEY MERGERS AND ACQUISITIONS)
  • COMPETITIVE LANDSCAPE IN THE CGM SYSTEM AND INSULIN PUMP MARKET
    • TABLE 65: GLOBAL MARKET FOR CGM SYSTEMS AND INSULIN PUMPS, BY LEADING COMPANIES, 2015 ($ MILLIONS)
    • FIGURE 34: GLOBAL MARKET SHARES OF CGM SYSTEMS AND INSULIN PUMPS MARKET BY LEADING COMPANIES, 2015 (%)
  • OTHER EMERGING DEVICE TECHNOLOGIES IN DIABETES CARE
    • Remote Diabetes Monitoring
    • Miniaturized Disposable Insulin Delivery Pumps
    • Glucose Sensing Bio-implants for Glucose Monitoring
    • Glucose Sensing Contact Lenses
    • Product using Near-Infra Red (NIR) Light to take Glucose Measurements in the Body
    • Intraperitoneal Islet Transplantation

CHAPTER 7 - EMERGING DIAGNOSTIC TECHNOLOGIES IN IN VITRO DIAGNOSTICS MARKET

  • MOLECULAR DIAGNOSTICS
  • EMERGING CANCER MOLECULAR AND COMPANION DIAGNOSTICS
    • CANCER MOLECULAR DIAGNOSTICS
    • COMPANION DIAGNOSTICS
      • TABLE 66 COMMON COMPANION DIAGNOSTIC TESTS AND DRUGS
    • MARKET SIZE AND GROWTH ANALYSIS
      • TABLE 67: GLOBAL MARKET FOR CANCER MOLECULAR DIAGNOSTICS, BY REGION, THROUGH 2021 ($ MILLIONS)
      • FIGURE 35: GLOBAL MARKET SHARES OF CANCER MOLECULAR DIAGNOSTICS, BY REGION, 2015 (%)
      • TABLE 68: GLOBAL MARKET FOR CANCER MOLECULAR DIAGNOSTICS, BY TYPE, 2015 ($ MILLIONS)
      • FIGURE 36: GLOBAL MARKET SHARES OF CANCER MOLECULAR DIAGNOSTICS, BY TYPE, 2015 (%)
      • TABLE 69: GLOBAL MARKET FOR COMPANION DIAGNOSTICS, BY REGION, THROUGH 2021 ($ MILLIONS)
      • FIGURE 37: GLOBAL MARKET SHARES OF COMPANION DIAGNOSTICS, BY REGION, 2015 (%)
      • Market Growth Drivers and Restraints
    • KEY MARKETED AND PIPELINE PRODUCTS
      • Recently FDA Approved Diagnostics
        • cobas KRAS Mutation Test (P140023) (Roche)
        • VENTANA ALK (D5F3) CDx Assay (P140025) (Ventana Medical Systems)
      • R&D Pipeline Device Technologies
        • ApoStream (from ApoCell)
        • "No Cell Left Behind" Platform (from Epic Sciences)
        • Genomic Bladder Cancer Liquid Biopsy Test (from Genomic Health)
        • Oncotype SEQ Liquid Mutation Panel (from Genomic Health)
        • Second-Generation Assay for Prostate Cancer (from Metamark Genetics)
        • Xpert Tests (from Cepheid)
        • Annexin A3 (from bioMerieux)
        • myPlan Renal Cancer, myPath Prostate Cancer, myPath Pancreatic Cancer (from Myriad Genetics)
        • OncoCEE (from Biocept)
          • TABLE 70: KEY R &D PIPELINE DIAGNOSTICS AND TECHNOLOGIES FOR CANCER MOLECULAR DIAGNOSTICS
        • Companion Diagnostic for Investigational anti-PD-L1 Antibody (from Agilent Technologies)
        • Glesatinib Companion Diagnostic Test (from Foundation Medicine)
        • Companion Diagnostic Test [Non-Small Cell Lung Cancer] (from QIAGEN)
        • Next-generation Sequencing (NGS) Oncology Test (from Thermo Fisher Scientific)
          • TABLE 71: KEY R &D PIPELINE DIAGNOSTICS AND TECHNOLOGIES FOR COMPANION DIAGNOSTICS
    • STRATEGIC DEALS (KEY MERGERS AND ACQUISITIONS)
      • Cancer Genetics acquired Response Genetics
      • Predictive Technology Group acquired Predictive Therapeutics - Remaining Shares
      • Biovica acquired cSens
      • Sysmex acquired Indivumed's Inostics and Inostics Inc. Subsidiaries (Germany, U.S.)
      • Nuclea Biotechnologies acquired Wilex's U.S. Subsidiary
        • TABLE 72: RECENT KEY STRATEGIC DEALS FOR MOLECULAR DIAGNOSTICS MARKET
    • COMPETITIVE LANDSCAPE IN ADVANCED CANCER MOLECULAR DIAGNOSTICS
      • TABLE 73: GLOBAL MARKET FOR ADVANCED CANCER MOLECULAR DIAGNOSTICS AND TECHNOLOGIES, BY LEADING COMPANIES, 2015
      • FIGURE 38: GLOBAL MARKET SHARES OF ADVANCED CANCER MOLECULAR DIAGNOSTICS AND TECHNOLOGIES, BY LEADING COMPANIES, 2015 (%)
    • OTHER EMERGING DIAGNOSTICS AND TECHNOLOGIES
      • Elecsys Anti-HCV II Immunoassay and Elecsys PreciControl Anti-HCV (P140021) (Roche)
      • Gastric Emptying Breath Test (GEBT) (P110015) (Advanced Breath Diagnostics)
      • cobas HBV (P150014) (Roche)
      • cobasHCV Test (P150015) (from Roche)
      • PD-L1 IHC 28-8 pharmDx (P150025) (from Dako North America)
  • POINT-OF-CARE (POC) DIAGNOSTICS
    • POC AND CANCER
    • MARKET SIZE AND GROWTH ANALYSIS
      • TABLE 74: GLOBAL MARKET FOR POC DIAGNOSTICS, BY REGION, THROUGH 2021 ($ MILLIONS)
      • FIGURE 39: GLOBAL MARKET SHARES OF POC DIAGNOSTICS, BY REGION, 2015 (%)
      • TABLE 75: GLOBAL MARKET FOR POC DIAGNOSTICS, BY TYPE, 2015 ($ MILLIONS)
      • FIGURE 40: GLOBAL MARKET SHARES OF POC DIAGNOSTICS, BY TYPE, 2015 (%)
      • Market Growth Drivers and Restraints
    • KEY MARKETED AND PIPELINE PRODUCTS
      • Recently FDA Approved Diagnostics
        • cobas KRAS Mutation Test (P140023) (Roche)
        • Atlas io Platform - Nucleic Acid Detection (from Consort Medical)
        • POC Hemorrhagic Fever Test (from Lucigen)
        • Portable POC System (from Ohmx)
        • Blood Tests for Mild Traumatic Brain Injuries (from Abbott Laboratories)
        • Alere q Analyzer (from Alere)
        • Handheld Biosensor Reader (from Ohmx)
        • OraQuick Ebola Rapid Antigen Test (from OraSure Technologies)
        • Liat Dengue Assay (from Roche)
        • Rinse and Spit Test (from Vigilant Biosciences)
          • TABLE 76: KEY R &D PIPELINE DIAGNOSTICS AND TECHNOLOGIES FOR POC DIAGNOSTICS
      • Key R&D Pipeline Diagnostics
    • STRATEGIC DEALS (RECENT KEY MERGERS AND ACQUISITIONS)
      • Sinocare acquired PTS Diagnostics
      • Abbott Laboratories acquiring Alere
      • Roche acquired IQuum
      • EKF Diagnostics acquired DiaSpect Medical
      • Becton Dickinson acquired Alverix
      • Radiometer Medical acquired Quest Diagnostics' HemoCue Business
      • Agenix acquired Diagnostic Technology from Tyrian
        • TABLE 77: RECENT KEY STRATEGIC DEALS FOR POC DIAGNOSTICS
    • COMPETITIVE LANDSCAPE IN POC DIAGNOSTICS
      • TABLE 78: GLOBAL MARKET FOR POC DIAGNOSTICS AND TECHNOLOGIES, BY LEADING COMPANIES, 2015 ($ MILLIONS)
      • FIGURE 41: GLOBAL MARKET SHARES OF MOLECULAR DIAGNOSTICS DEVICE TECHNOLOGIES, BY LEADING COMPANIES, 2015 (%)
    • FUTURE OUTLOOK OF POC

CHAPTER 8 - NEEDLE-FREE DRUG DELIVERY TECHNOLOGIES

  • NEEDLE-FREE DRUG DELIVERY TECHNOLOGIES
    • MARKET SIZE AND GROWTH ANALYSIS
      • TABLE 79: GLOBAL MARKET FOR NEEDLE-FREE DRUG DELIVERY TECHNOLOGIES, BY REGION, THROUGH 2021 ($ MILLIONS)
      • FIGURE 42: GLOBAL MARKET SHARES OF NEEDLE-FREE DRUG DELIVERY TECHNOLOGIES, BY REGION, 2015 (%)
  • MARKETED AND R&D PIPELINE PRODUCTS
    • KEY MARKETED PRODUCTS
      • Medi-Jector Vision Needle-Free Injector
      • Vibex Pressure Assisted Auto Injection System
      • Antares Pen Injector
      • Otrexup
      • Sumavel DosePro Needle-Free Delivery System
      • Biojector 2000 Needle-Free Injection System
      • Cool.click Needle-Free Injection System
      • AdvantaJet
      • PenJet Needle-Free System
      • Stratis Needle-Free System
      • Mini-Ject Needle-Free System
      • h-Patch
      • Micro-Trans
      • Short-Acting Bronchodilators
      • Corticosteroids
    • R&D PIPELINE PRODUCTS
      • Lapas (from Consort Medical)
      • Automated Reconstitution Auto Injector and Bespak Semi-Disposable Auto Injector (from Consort Medical)
      • RITA Autoinjector (from Unilife)
      • LISA Autoinjector (from Unilife)
      • Nanopatch (from Vaxxas)
      • WindGap Medical Pre-Filled Automatic Injection Device (from WindGap Medical)
      • DEV200 Nicotine Inhaler Device (from Consort Medical)

CHAPTER 9 - EMERGING DEVICE TECHNOLOGIES IN GI ENDOSCOPY MARKET

  • SMART PILLS AND TECHNOLOGIES
    • CAPSULE ENDOSCOPY
    • MARKET SIZE AND GROWTH ANALYSIS
      • TABLE 80: GLOBAL MARKET FOR SMART PILLS AND TECHNOLOGIES, THROUGH 2021 ($ MILLIONS)
    • CURRENT DEVELOPMENTS AND R&D PIPELINE PRODUCTS
      • PillCam for Ulcerative Colitis/Crohn's Disease (from Medtronic)
      • PillCam SBC System (from Medtronic)
  • INTRAGASTRIC BALLOON SYSTEMS
    • OBESITY AND NEED OF INTRAGASTRIC BALLOONS
      • Growing Obesity Populations Worldwide
        • TABLE 81: TRENDS IN OBESITY COMPOSITION OF THE WORLD POPULATION, THROUGH 2020 ($ MILLIONS)
        • TABLE 82: U.S. OBESITY AND SEVERE OBESITY VS. GENERAL POPULATION, THROUGH 2020 (MILLIONS)
    • MARKET SIZE AND GROWTH ANALYSIS
      • TABLE 83: GLOBAL MARKET FOR INTRAGASTRIC BALLOON SYSTEMS, THROUGH 2021 ($ MILLIONS)
    • MARKETED AND R&D PIPELINE PRODUCTS
      • Recently FDA Approved devices
        • ORBERA Intragastric Balloon System (P140008) (Apollo Endosurgery)
        • ReShape Integrated Dual Balloon System (P140012) (ReShape Medical)
      • R&D Pipeline Products
        • Digestible Balloon (from PlenSat)
        • Digestible Balloon (from Tulip Medical)
        • Spatz3 Adjustable Balloon
        • Silimed Gastric Balloon (from Sientra)

CHAPTER 10 - OTHER EMERGING MEDICAL DEVICE TECHNOLOGIES

  • IOL AND CORNEA IMPLANTS
    • MARKET SIZE AND GROWTH ANALYSIS
      • TABLE 84: GLOBAL MARKET FOR IOL, BY REGION, THROUGH 2021 ($ MILLIONS)
    • MARKETED AND R&D PIPELINE PRODUCTS
      • Recently FDA Approved Devices
        • KAMRA Inlay (P120023) (AcuFocus)
        • AcrySof IQ ReSTOR +2.5 D Multifocal IOL, Model SV25T
        • (P040020/S050) (Alcon Laboratories)
      • R&D Pipeline Products
        • Mirricon (from ClearSight Innovations)
        • Actalens (from Emmetrope)
        • ClearSight IOL (from ClearSight)
        • AcrySof IQ, ReSTOR Toric IO (from Novartis)
        • PRIMA System (from Pixium Vision)
    • CATARACTS AND IOL
    • STANDARD MONOFOCAL VS PREMIUM IOLS
  • ADVANCED WOUND MANAGEMENT
    • ADVANCED WOUND DRESSINGS
    • NEGATIVE PRESSURE WOUND THERAPY
    • MARKET SIZE AND GROWTH ANALYSIS
      • TABLE 85: GLOBAL MARKET FOR ADVANCED WOUND MANAGEMENT (AWM) DEVICE TECHNOLOGIES, BY TYPE, THROUGH 2021 ($ MILLIONS)
    • MARKETED AND R&D PIPELINE PRODUCTS
      • Recently FDA Approved Devices
        • Progel Pleural Air Leak Sealant (P010047/S036) (NeoMend)
        • Adherus AutoSpray Dural Sealant (P130014) (HyperBranch Medical Technology)
      • R&D Pipeline Products
        • Senna (from BioRegen Biomedical)
        • Progell Vascular Sealant (from C. R. Bard)
        • Endomedix Hydrogel Sealant (from Endomedix)
        • Endomedix Topical Hemostat (from Endomedix)
        • Endomedix Wound Care (from Endomedix)
        • Scaffolene Plus GDF-5 (from Freudenberg)
        • Fibrin Sealant Grifols (from Grifols)
        • EpiBurn (from MiMedx Group)
        • Leia Dressings (from Molnlycke Health Care)
        • IMPLANTABLE DRUG DIFFUSION PUMPS
        • KEY R&D PIPELINE DEVICE TECHNOLOGIES
        • Implantable Drug Delivery System (IDDS) (from Palyon Medical)
        • Micro-Dosing System (from Palyon Medical)
  • ENDOLUMINAL PROCEDURES
  • MULTIPARAMETER VITAL SIGNS MONITORS
  • NONINVASIVE BLOOD PRESSURE (NIBP) MONITORS
  • HEMODIALYSIS AND PERITONEAL DIALYSIS
    • HEMODIALYSIS
    • PERITONEAL DIALYSIS
  • BIOCHIPS ARE MICROCHIP-BASED SENSORS
  • EAR IMPLANTS
    • KEY R&D PIPELINE PRODUCTS
      • Cochlear Nucleus Hybrid S12 (from Cochlear)
      • Nucleus CI532 Cochlear Implant (from Cochlear)
      • AventaMed ENT Device (from AventaMed)
  • MAMMOGRAPHY
    • RECENTLY FDA APPROVED DEVICES
      • MAMMOMAT Inspiration with Tomosynthesis (P140011) (Siemens Medical)
  • ROBOTICS AND COMPUTER-ASSISTED SURGERY
    • SURGICAL PLANNERS AND SIMULATORS
    • SURGICAL NAVIGATION SYSTEMS
    • SURGICAL ROBOTS
    • DIGITAL OPERATING ROOMS AND EQUIPMENT
  • SURGICAL LASERS
    • MARKETED AND R&D PIPELINE PRODUCTS
      • Recently FDA Approved Devices
        • STAR S4 IR Excimer Laser System and iDesign Advanced WaveScan Studio System (P930016/S044) (AMO Manufacturing)
      • R&D Pipeline Products
        • Next-generation Laser (from AngioDynamics)
        • StarFire Laser (from Boston Scientific)
  • POSITRON EMISSION TOMOGRAPHY
    • KEY PRODUCTS
      • Biograph mMR Whole-Body Integrated MR-PET System
      • PET + MR Sequential Imaging System
  • OPTICAL IMAGING
    • TIME DOMAIN (TD) OPTICAL IMAGING
    • CT LASER MAMMOGRAPHY (CTLM)
    • OPTICAL COHERENCE TOMOGRAPHY (OCT)
    • SCANNING LASER POLARIMETRY (SLP)
    • SCANNING LASER OPTHALMOSCOPY (SLO)
    • FLUORESCENCE SPECTROSCOPY
  • OTHER FDA APPROVED AND R&D PIPELINE DEVICE TECHNOLOGIES
    • RESQCPR SYSTEM: RESQPUMP (ACD-CPR DEVICE) AND RESQPOD ITD
    • (P110024) (ADVANCED CIRCULATORY SYSTEMS)
    • LIXELLE BETA 2-MICROGLOBULIN APHERESIS COLUMN (H130001) (KANEKA PHARMA AMERICA)
    • REJIVA (FROM RIJUVEN)
    • VENASEAL CLOSURE SYSTEM (P140018) (COVIDIEN)
    • ASPIREASSIST (P150024) (FROM ASPIRE BARIATRICS)
    • ENTEROMEDICS MAESTRO RECHARGEABLE SYSTEM (P130019) (FROM ENTEROMEDICS)
    • CIRLE SURGICAL NAVIGATION SYSTEM (FROM VALEANT PHARMACEUTICALS INTERNATIONAL)

CHAPTER 11 - REGULATORY STRUCTURE

  • UNITED STATES
  • EUROPEAN UNION
    • TABLE 86: DIFFERENCES IN REGULATORY APPROVAL IN THE U.S. VS. EUROPE
  • JAPAN
  • OTHER ASIA
    • CHINA
      • Hong Kong
    • KOREA
    • TAIWAN
    • INDIA
  • FDA TECHNICAL CONSIDERATIONS
  • FDA RECALLS AND SAFETY ALERTS

CHAPTER 12 - PRICING AND REIMBURSEMENT

  • UNITED STATES
    • ICD-9-CM
    • ICD-10
  • EUROPE
  • JAPAN
  • OTHER ASIA

CHAPTER 13 - CONCLUSIONS: OUTLOOK FOR EMERGING MEDICAL DEVICE TECHNOLOGIES

  • MAJOR DEVELOPMENTS TO INFLUENCE MARKET
    • TECHNOLOGICAL DEVELOPMENTS: ADAPTATION OF MINIMALLY INVASIVE AND NON-INVASIVE TECHNIQUES
    • DEMOGRAPHIC AND ECONOMIC TRENDS: INCOME GROWTH IN DEVELOPING MARKETS
      • TABLE 87: TRENDS IN PER CAPITA REAL GDP GROWTH BY REGION, 2012-2015 (ANNUAL AVERAGE PERCENTAGE CHANGE)
    • CHANGING STRUCTURE OF THE HEALTH CARE INDUSTRY
      • Hospital Consolidation
      • Medical Tourism
      • Health Insurance Developments
  • LONG-TERM OUTLOOK FOR BARIATRIC SURGERY DEVICES AND SERVICES

CHAPTER 14 - COMPANY PROFILES

  • 3M
  • 480 BIOMEDICAL
  • ABBOTT LABORATORIES
  • ACCUMED SYSTEMS INC.
  • AC-GEN READING LIFE
  • ACTUATED MEDICAL
  • ADIENT MEDICAL
  • ADVANCED RESEARCH TECHNOLOGIES INC.
  • AEGERIA SOFT TISSUE
  • AETHLON MEDICAL INC.
  • AFREEZE
  • ALERE INC.
  • ALLERGAN PLC
  • ALLURION TECHNOLOGIES
  • AMARANTH MEDICAL
  • A.M.I. (AGENCY FOR MEDICAL INNOVATIONS)
  • ANGIODYNAMICS
  • APAMA MEDICAL
  • APPLIED MEDICAL
  • APOLLO ENDOSURGERY
  • APOCELL
  • ASPIRE BARIATRICS
  • ATRICURE
  • AUDAX MEDICAL
  • BARD
  • BARONOVA
  • BAROSENSE (SUBSIDIARY OF BOSTON SCIENTIFIC)
  • BAXTER INTERNATIONAL INC.
  • BELLEROPHON THERAPEUTICS
  • BETA-STIM LTD.
  • BFKW
  • BIOCEPT
  • BIOMERIEUX
  • BIONESS
  • BIO-SCAFFOLD INTERNATIONAL
  • BIOSENSE WEBSTER INC. (SUBSIDIARY OF JOHNSON & JOHNSON)
  • BIOSURFACE ENGINEERING TECHNOLOGIES
  • BIOTHERANOSTICS
  • BIOTRONIK
  • BOSTON SCIENTIFIC CORP.
  • BRACCO
  • CALLISYN BIOMEDICAL INC.
  • CARDIOSOLUTIONS INC.
  • CARDIOVASCULAR SYSTEMS INC.
  • CARMELL THERAPEUTICS CORP.
  • CERVEL NEUROTECH
  • COLIBRI HEART VALVE
  • COOK GROUP INC.
  • CONSORT MEDICAL
  • CORAMAZE TECHNOLOGIES GMBH
  • CORAS MEDICAL
  • CROSPON
  • CVTEC CEREBROVASCULAR TECHNOLOGIES
  • EDWARDS LIFESCIENCES
  • ELECTRICAL GEODESICS INC.
  • ELIXIR MEDICAL
  • ENDOBETIX
  • ENDOGASTRIC SOLUTIONS
  • ENDOLOGIX
  • ENDORETICS INC.
  • ENDOSPHERE
  • ENDOSPAN
  • ENTEROMEDICS INC.
  • GAUDI VASCULAR
  • GELESIS
  • GENTIS
  • GETINGE AB
  • GI DYNAMICS
  • GI WINDOWS INC.
  • GREATBATCH
  • GUIDED DELIVERY SYSTEMS
  • HANSEN MEDICAL INC.
  • HARPOON MEDICAL
  • HEARTWARE
  • HELIOSCOPIE
  • HOLOGIC
  • ICELLATE
  • ILLUMINA
  • IMPLANTS INTL.
  • INIVATA LTD.
  • INSPIREMD
  • INTEGRA LIFESCIENCES
  • INTERFACE BIOLOGICS
  • INTRAPACE INC.
  • INVIVO THERAPEUTICS CORP.
  • JENAVALVE TECHNOLOGY
  • KEYSTONE HEART
  • LIFETECH SCIENTIFIC
  • LIVANOVA
  • LOMBARD MEDICAL TECHNOLOGIES
  • LONESTAR HEART INC.
  • LUCIGEN
  • MAINSTAY MEDICAL
  • MEDTRONIC
  • METACURE
  • METAMARK GENETICS
  • MICARDIA CORP.
  • MICROPORT SCIENTIFIC
  • MICROTRANSPONDER
  • MINDRAY MEDICAL INTERNATIONAL LTD.
  • MIRACA HOLDINGS
  • MITRASSIST
  • MSDX INC.
  • MYRIAD GENETICS INC.
  • NANONERVE INC.
  • NEOVASC
  • NESHER TECHNOLOGIES INC.
  • NEUROMETRIX
  • NEURORECOVERY TECHNOLOGIES
  • NOVARTIS
  • OBALON THERAPEUTICS
  • OHMX
  • ONCIOMED INC.
  • ONCOGENESIS
  • OPTO CIRCUITS (INDIA) LTD.
  • ORASURE TECHNOLOGIES
  • ORPYX MEDICAL TECHNOLOGIES INC.
  • ORTHOFIX INTL.
  • OSTEOTEC LTD.
  • PALMAZ SCIENTIFIC INC.
  • PENUMBRA
  • PLENSAT INC.
  • QUANTERIX CORP.
  • RENISHAW
  • RESHAPE MEDICAL
  • REVA MEDICAL INC.
  • RIJUVEN
  • SARL COUSIN BIOTECH
  • SATIETY INC.
  • SCIENTIFIC INTAKE
  • SENSATE
  • SETPOINT MEDICAL
  • SHAPE MEMORY MEDICAL INC.
  • SKLAR CORP.
  • SLIMEDICS LTD.
  • SMITH & NEPHEW
  • SOFT TISSUE REGENERATION INC.
  • SOTERIX MEDICAL INC.
  • SPATZ FGIA
  • SPECTRANETICS
  • ST. JUDE MEDICAL
  • STRYKER
  • SYMETIS
  • SYSMEX CORP.
  • TAL MEDICAL
  • TERUMO CORP.
  • TISSUE REGENERATION SYSTEMS
  • TISSUE REGENIX GROUP PLC
  • TOMOWAVE LABORATORIES
  • TORNIER INC.
  • TRANSCATHETER TECHNOLOGIES
  • TRANSENTERIX
  • TRIVITRON HEALTHCARE
  • TTK HEALTHCARE
  • TULIP MEDICAL LTD.
  • USGI MEDICAL
  • VALEANT PHARMACEUTICALS INTL.
  • VALENTX
  • VIGILANT BIOSCIENCES
  • W. L. GORE AND ASSOCIATES
  • WRIGHT MEDICAL TECHNOLOGY INC.
  • XELTIS
  • YPSOMED HOLDING AG
  • ZIMMER BIOMET

CHAPTER 15 - APPENDIX A INDUSTRY AND PROFESSIONAL ORGANIZATIONS

  • AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR)
  • AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE (ASRM)
  • AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO)
  • CENTER FOR DEVICES AND RADIOLOGICAL HEALTH
  • CENTERS FOR MEDICARE & MEDICAID SERVICES
  • EUDAMED
  • FOOD AND DRUG ADMINISTRATION (FDA)
  • GLOBAL CANCER FOUNDATION
  • HORMONE FOUNDATION
  • INTERNATIONAL AGENCY FOR RESEARCH ON CANCER
  • INTERNATIONAL FEDERATION OF PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS (IFPMA)
  • INTERNATIONAL OSTEOPOROSIS FOUNDATION (IOF)
  • INTERNATIONAL DIABETES FEDERATION (IDF)
  • NATIONAL CENTER FOR BIOTECHNOLOGY INFORMATION (NCBI)
  • NATIONAL INSTITUTE OF AGING (NIA)
  • PMDA
  • WORLD CANCER RESEARCH FUND INTERNATIONAL

CHAPTER 16 - APPENDIX B: ABBREVIATIONS

LIST OF TABLES

  • SUMMARY TABLE: GLOBAL MARKET FOR EMERGING MEDICAL DEVICE TECHNOLOGIES, BY SEGMENT, THROUGH 2021 ($ MILLIONS)
    • TABLE 1: GLOBAL PREVALENCE OF ANGINA PECTORIS AND STROKE (SURVIVORS), THROUGH 2030 (THOUSANDS)
    • TABLE 2: GLOBAL INCIDENCE OF STROKE AND CONGESTIVE HEART FAILURE, THROUGH 2030 (THOUSANDS)
    • TABLE 3: GLOBAL DEATHS, BY CARDIOVASCULAR DISEASE, THROUGH 2030 (THOUSANDS)
    • TABLE 4: GLOBAL MARKET FOR EMERGING HEART FAILURE DEVICE TECHNOLOGIES, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 5: GLOBAL MARKET FOR EMERGING HEART FAILURE DEVICE TECHNOLOGIES, BY TYPE, 2015 ($ MILLIONS)
    • TABLE 6: R &D PIPELINE DEVICE TECHNOLOGIES FOR HEART FAILURE
    • TABLE 7: RECENT KEY STRATEGIC DEALS IN HEART FAILURE DEVICES TECHNOLOGIES, 2013-2015
    • TABLE 8: GLOBAL MARKET FOR ELECTROPHYSIOLOGY DEVICE TECHNOLOGIES, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 9: GLOBAL MARKET FOR ELECTROPHYSIOLOGY DEVICE TECHNOLOGIES, BY TYPE, 2015 ($ MILLIONS)
    • TABLE 10: GLOBAL MARKET FOR ELECTROPHYSIOLOGY, BY TYPE, 2015 ($ MILLIONS)
    • TABLE 11: KEY R &D PIPELINE DEVICE TECHNOLOGIES IN ELECTROPHYSIOLOGY
    • TABLE 12: RECENT KEY STRATEGIC DEALS IN ELECTROPHYSIOLOGY
    • TABLE 13: GLOBAL MARKET FOR INTERVENTIONAL CARDIOLOGY DEVICE TECHNOLOGIES, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 14: GLOBAL MARKET FOR INTERVENTIONAL CARDIOLOGY DEVICE TECHNOLOGIES, BY TYPE, 2015 ($ MILLIONS)
    • TABLE 15: KEY R &D PIPELINE DEVICE TECHNOLOGIES FOR BIORESORBABLE VASCULAR SCAFFOLD (BVS)
    • TABLE 16: RECENT KEY STRATEGIC DEALS FOR INTERVENTIONAL CARDIOLOGY, 2012-2015
    • TABLE 17: EPIDEMIOLOGY OF AAA AND TAA
    • TABLE 18: GLOBAL NUMBER OF AORTIC ANEURYSM REPAIR PROCEDURES, BY PROCEDURE TYPE, 2015 (NO.)
    • TABLE 19: GLOBAL MARKET FOR EVAR AND TEVAR, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 20: GLOBAL MARKET OF EVAR AND TEVAR, BY ANEURYSM TYPE, 2015 ($ MILLIONS)
    • TABLE 21: KEY R &D PIPELINE DEVICE TECHNOLOGIES FOR ENDOVASCULAR AORTIC REPAIR
    • TABLE 22: GLOBAL MARKET FOR S-ICD, THROUGH 2021 ($ MILLIONS)
    • TABLE 23: RECENTLY FDA APPROVED S-ICD DEVICE TECHNOLOGIES
    • TABLE 24: GLOBAL MARKET FOR PERIPHERAL VASCULAR DEVICE TECHNOLOGIES, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 25: GLOBAL MARKET FOR PERIPHERAL VASCULAR DEVICE TECHNOLOGIES, BY TYPE, 2015 ($ MILLIONS)
    • TABLE 26: KEY R &D PIPELINE DEVICE TECHNOLOGIES FOR PERIPHERAL VASCULAR MARKET
    • TABLE 27: RECENT KEY STRATEGIC DEALS FOR PERIPHERAL VASCULAR DEVICE TECHNOLOGIES, 2012-2015
    • TABLE 28: GLOBAL MARKET FOR TRANSCATHETER HEART VALVE TECHNOLOGIES, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 29: KEY R &D PIPELINE DEVICE TECHNOLOGIES FOR TRANSCATHETER HEART VALVE MARKET
    • TABLE 30: RECENT KEY STRATEGIC DEALS FOR TRANSCATHETER HEART VALVE MARKET, 2010-2016
    • TABLE 31: GLOBAL MARKET FOR EMERGING CARDIOVASCULAR DEVICE TECHNOLOGIES, BY LEADING COMPANIES, 2015 ($ MILLIONS)
    • TABLE 32: GLOBAL SYMPTOMATIC PREVALENCE OF KEY MUSCULOSKELETAL DISORDERS, BY TYPE, THROUGH 2021 (THOUSANDS)
    • TABLE 33: GLOBAL DEATHS, BY MUSCULOSKELETAL DISORDER, THROUGH 2030 (NO.)
    • TABLE 34: GLOBAL EXTREMITY JOINT RECONSTRUCTION PROCEDURES, BY TYPE, THROUGH 2021 (NO.)
    • TABLE 35: GLOBAL MARKET FOR EXTREMITY JOINT RECONSTRUCTION DEVICE TECHNOLOGIES, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 36: GLOBAL MARKET FOR EXTREMITY JOINT RECONSTRUCTION DEVICE TECHNOLOGIES, BY TYPE, 2015 ($ MILLIONS)
    • TABLE 37: GLOBAL MARKET FOR SMALL JOINT RECONSTRUCTION DEVICE TECHNOLOGIES, BY TYPE, 2015 ($ MILLIONS)
    • TABLE 38: RECENTLY APPROVED DEVICE TECHNOLOGIES FOR EXTREMITY JOINT RECONSTRUCTION AND REPLACEMENT
    • TABLE 39: KEY R &D PIPELINE DEVICE TECHNOLOGIES FOR EXTREMITY JOINT RECONSTRUCTION
    • TABLE 40: GLOBAL MARKET FOR SOFT TISSUE FIXATION AND REPAIR DEVICE TECHNOLOGIES, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 41: GLOBAL MARKET FOR SOFT TISSUE FIXATION AND REPAIR DEVICE TECHNOLOGIES, BY TYPE, 2015 ($ MILLIONS)
    • TABLE 42: RECENTLY APPROVED DEVICE TECHNOLOGIES FOR SOFT TISSUE FIXATION AND REPAIR
    • TABLE 43: KEY R &D PIPELINE DEVICE TECHNOLOGIES FOR SOFT TISSUE FIXATION AND REPAIR
    • TABLE 44: LEADING COMPANIES IN THE GLOBAL MARKET FOR EMERGING ORTHOPEDIC DEVICE TECHNOLOGIES, 2015 ($ MILLIONS)
    • TABLE 45: TARGET DEVICE TECHNOLOGIES FOR KEY DISEASE INDICATIONS
    • TABLE 46: GLOBAL MARKET FOR NEUROVASCULAR DEVICE TECHNOLOGIES, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 47: GLOBAL MARKET FOR NEUROVASCULAR DEVICE TECHNOLOGIES, BY TYPE, 2015 ($ MILLIONS)
    • TABLE 48: RECENTLY APPROVED DEVICE TECHNOLOGIES FOR NEUROVASCULAR MARKET
    • TABLE 49: KEY R &D PIPELINE DEVICE TECHNOLOGIES FOR NEUROVASCULAR MARKET
    • TABLE 50: RECENT KEY STRATEGIC DEALS FOR NEUROVASCULAR MARKET, 2010-2016
    • TABLE 51: GLOBAL MARKET FOR NEUROVASCULAR DEVICE TECHNOLOGIES, BY LEADING COMPANIES, 2015 ($ MILLIONS)
    • TABLE 52: NEUROMODULATION DEVICES AND TARGET DISEASE INDICATIONS
    • TABLE 53: GLOBAL MARKET FOR NEUROMODULATION DEVICE TECHNOLOGIES, BY REGION, 2015-2021 ($ MILLIONS)
    • TABLE 54: GLOBAL MARKET FOR NEUROMODULATION DEVICE TECHNOLOGIES, BY TYPE, 2015 ($ MILLIONS)
    • TABLE 55: KEY NEUROMODULATION PRODUCT BRANDS FROM LEADING PLAYERS
    • TABLE 56: RECENTLY APPROVED DEVICE TECHNOLOGIES FOR NEUROMODULATION MARKET
    • TABLE 57: KEY R &D PIPELINE DEVICE TECHNOLOGIES FOR NEUROMODULATION MARKET
    • TABLE 58: RECENT KEY STRATEGIC DEALS FOR NEUROMODULATION MARKET
    • TABLE 59: GLOBAL MARKET FOR NEUROMODULATION DEVICES AND TECHNOLOGIES, BY LEADING COMPANIES, 2015 ($ MILLIONS)
    • TABLE 60: GLOBAL PREVALENCE OF DIABETES, THROUGH 2040 ($ MILLIONS)
    • TABLE 61: GLOBAL MARKET FOR CGMS AND INSULIN PUMPS, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 62: GLOBAL MARKET FOR CGM SYSTEMS AND INSULIN PUMP, BY TYPE, 2015 ($ MILLIONS)
    • TABLE 63: KEY R &D PIPELINE DEVICES FOR CGM SYSTEMS
    • TABLE 64: KEY R &D PIPELINE DEVICES FOR INSULIN PUMPS
    • TABLE 65: GLOBAL MARKET FOR CGM SYSTEMS AND INSULIN PUMPS, BY LEADING COMPANIES, 2015 ($ MILLIONS)
    • TABLE 66: COMMON COMPANION DIAGNOSTIC TESTS AND DRUGS
    • TABLE 67: GLOBAL MARKET FOR CANCER MOLECULAR DIAGNOSTICS, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 68: GLOBAL MARKET FOR CANCER MOLECULAR DIAGNOSTICS, BY TYPE, 2015 ($ MILLIONS)
    • TABLE 69: GLOBAL MARKET FOR COMPANION DIAGNOSTICS, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 70: KEY R &D PIPELINE DIAGNOSTICS AND TECHNOLOGIES FOR CANCER MOLECULAR DIAGNOSTICS
    • TABLE 71: KEY R &D PIPELINE DIAGNOSTICS AND TECHNOLOGIES FOR COMPANION DIAGNOSTICS
    • TABLE 72: RECENT KEY STRATEGIC DEALS FOR MOLECULAR DIAGNOSTICS MARKET
    • TABLE 73: GLOBAL MARKET FOR ADVANCED CANCER MOLECULAR DIAGNOSTICS AND TECHNOLOGIES, BY LEADING COMPANIES, 2015
    • TABLE 74: GLOBAL MARKET FOR POC DIAGNOSTICS, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 75: GLOBAL MARKET FOR POC DIAGNOSTICS, BY TYPE, 2015 ($ MILLIONS)
    • TABLE 76: KEY R &D PIPELINE DIAGNOSTICS AND TECHNOLOGIES FOR POC DIAGNOSTICS
    • TABLE 77: RECENT KEY STRATEGIC DEALS FOR POC DIAGNOSTICS
    • TABLE 78: GLOBAL MARKET FOR POC DIAGNOSTICS AND TECHNOLOGIES, BY LEADING COMPANIES, 2015 ($ MILLIONS)
    • TABLE 79: GLOBAL MARKET FOR NEEDLE-FREE DRUG DELIVERY TECHNOLOGIES, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 80: GLOBAL MARKET FOR SMART PILLS AND TECHNOLOGIES, THROUGH 2021 ($ MILLIONS)
    • TABLE 81: TRENDS IN OBESITY COMPOSITION OF THE WORLD POPULATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 82: U.S. OBESITY AND SEVERE OBESITY VS. GENERAL POPULATION, THROUGH 2020 (MILLIONS)
    • TABLE 83: GLOBAL MARKET FOR INTRAGASTRIC BALLOON SYSTEMS, THROUGH 2021 ($ MILLIONS)
    • TABLE 84: GLOBAL MARKET FOR IOL, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 85: GLOBAL MARKET FOR ADVANCED WOUND MANAGEMENT (AWM) DEVICE TECHNOLOGIES, BY TYPE, THROUGH 2021 ($ MILLIONS)
    • TABLE 86: DIFFERENCES IN REGULATORY APPROVAL IN THE U.S. VS. EUROPE
    • TABLE 87: TRENDS IN PER CAPITA REAL GDP GROWTH BY REGION, 2012-2015 (ANNUAL AVERAGE PERCENTAGE CHANGE)

LIST OF FIGURES

  • SUMMARY FIGURE: GLOBAL MARKET FOR EMERGING MEDICAL DEVICE TECHNOLOGIES, BY SEGMENT, 2015-2021 ($ MILLIONS)
    • FIGURE 1: HYPERTENSION EPIDEMIOLOGY, BY PATIENT GROUP, 2015 (% OF TOTAL PATIENTS)
    • FIGURE 2: DISTRIBUTION OF GLOBAL DEATHS, BY CARDIOVASCULAR DISEASE, 2015 (% OF TOTAL DEATHS DUE TO CARDIOVASCULAR DISEASES)
    • FIGURE 3: GLOBAL MARKET SHARES FOR EMERGING HEART FAILURE DEVICE TECHNOLOGIES, BY REGION, 2015 (%)
    • FIGURE 4: GLOBAL MARKET SHARES OF EMERGING HEART FAILURE DEVICE TECHNOLOGIES, BY TYPE, 2015 (%)
    • FIGURE 5: GLOBAL MARKET SHARES OF ELECTROPHYSIOLOGY DEVICE TECHNOLOGIES, BY REGION, 2015 (%)
    • FIGURE 6: GLOBAL MARKET SHARES OF ELECTROPHYSIOLOGY DEVICE TECHNOLOGIES, BY TYPE, 2015 (%)
    • FIGURE 7: GLOBAL MARKET SHARES OF ELECTROPHYSIOLOGY, BY TYPE, 2015 (%)
    • FIGURE 8: GLOBAL MARKET SHARES OF INTERVENTIONAL CARDIOLOGY DEVICE TECHNOLOGIES, BY REGION, 2015 (%)
    • FIGURE 9: GLOBAL MARKET SHARES OF INTERVENTIONAL CARDIOLOGY DEVICE TECHNOLOGIES, BY TYPE, 2015 (%)
    • FIGURE 10: U.S. AAA PROCEDURES, BY SURGERY TYPE, 2015 (%)
    • FIGURE 11: GLOBAL MARKET SHARES OF EVAR AND TEVAR, BY REGION, 2015-2021 (%)
    • FIGURE 12: GLOBAL MARKET SHARES FOR EVAR AND TEVAR, BY ANEURYSM TYPE, 2015 (%)
    • FIGURE 13: GLOBAL MARKET SHARES OF PERIPHERAL VASCULAR DEVICE TECHNOLOGIES, BY REGION, 2015 (%)
    • FIGURE 14: GLOBAL MARKET SHARES OF PERIPHERAL VASCULAR DEVICE TECHNOLOGIES, BY TYPE, 2015 (%)
    • FIGURE 15: GLOBAL MARKET SHARES OF TRANSCATHETER HEART VALVE TECHNOLOGIES, BY REGION, 2015 (%)
    • FIGURE 16: GLOBAL MARKET SHARES OF LEADING COMPANIES IN EMERGING CARDIOVASCULAR DEVICE TECHNOLOGIES, 2016 (%)
    • FIGURE 17: DISTRIBUTION OF GLOBAL SYMPTOMATIC PREVALENCE OF KEY MUSCULOSKELETAL DISORDERS, BY REGION, 2015 (THOUSANDS)
    • FIGURE 18: DISTRIBUTION OF GLOBAL DEATHS, BY MUSCULOSKELETAL DISORDER, 2015 (% OF TOTAL DEATHS DUE TO MUSCULOSKELETAL DISORDERS)
    • FIGURE 19: GLOBAL MARKET SHARES OF EXTREMITY JOINT RECONSTRUCTION DEVICE TECHNOLOGIES, BY REGION, 2015 (%)
    • FIGURE 20: GLOBAL MARKET SHARES OF EXTREMITY JOINT RECONSTRUCTION DEVICE TECHNOLOGIES, BY TYPE, 2015 (%)
    • FIGURE 21: GLOBAL MARKET SHARES OF SMALL JOINT RECONSTRUCTION DEVICE TECHNOLOGIES, BY TYPE, 2015 (%)
    • FIGURE 22: GLOBAL MARKET SHARES OF SOFT TISSUE FIXATION AND REPAIR DEVICE TECHNOLOGIES, BY REGION, 2015 (%)
    • FIGURE 23: GLOBAL MARKET SHARES OF SOFT TISSUE FIXATION AND REPAIR DEVICE TECHNOLOGIES, BY TYPE, 2015 (%)
    • FIGURE 24: GLOBAL MARKET SHARES OF LEADING COMPANIES IN EMERGING CARDIOVASCULAR DEVICE TECHNOLOGIES, 2015 (%)
    • FIGURE 25: GLOBAL MARKET SHARES OF NEUROVASCULAR DEVICE TECHNOLOGIES, BY REGION, 2015 (%)
    • FIGURE 26: GLOBAL MARKET SHARES OF NEUROVASCULAR DEVICE TECHNOLOGIES, BY TYPE, 2015 (%)
    • FIGURE 27: GLOBAL MARKET SHARES OF CEREBRAL ANEURYSM DEVICE TECHNOLOGIES, BY TYPE, 2015 (%)
    • FIGURE 28: GLOBAL MARKET SHARES OF NEUROVASCULAR DEVICE TECHNOLOGIES, BY LEADING COMPANIES, 2015 (%)
    • FIGURE 29: GLOBAL MARKET SHARES OF NEUROMODULATION DEVICE TECHNOLOGIES, BY REGION, 2015 (%)
    • FIGURE 30: GLOBAL MARKET SHARES OF NEUROMODULATION DEVICE TECHNOLOGIES, BY TYPE, 2015 (%)
    • FIGURE 31: GLOBAL MARKET SHARES OF NEUROMODULATION DEVICES AND TECHNOLOGIES, BY LEADING COMPANIES, 2015 (%)
    • FIGURE 32: GLOBAL MARKET SHARES OF CGMS AND INSULIN PUMPS, BY REGION, 2015 (%)
    • FIGURE 33: GLOBAL MARKET SHARES OF CGM SYSTEMS AND INSULIN PUMP, BY TYPE, 2015 (%)
    • FIGURE 34: GLOBAL MARKET SHARES OF CGM SYSTEMS AND INSULIN PUMPS MARKET BY LEADING COMPANIES, 2015 (%)
    • FIGURE 35: GLOBAL MARKET SHARES OF CANCER MOLECULAR DIAGNOSTICS, BY REGION, 2015 (%)
    • FIGURE 36: GLOBAL MARKET SHARES OF CANCER MOLECULAR DIAGNOSTICS, BY TYPE, 2015 (%)
    • FIGURE 37: GLOBAL MARKET SHARES OF COMPANION DIAGNOSTICS, BY REGION, 2015 (%)
    • FIGURE 38: GLOBAL MARKET SHARES OF ADVANCED CANCER MOLECULAR DIAGNOSTICS AND TECHNOLOGIES, BY LEADING COMPANIES, 2015 (%)
    • FIGURE 39: GLOBAL MARKET SHARES OF POC DIAGNOSTICS, BY REGION, 2015 (%)
    • FIGURE 40: GLOBAL MARKET SHARES OF POC DIAGNOSTICS, BY TYPE, 2015 (%)
    • FIGURE 41: GLOBAL MARKET SHARES OF MOLECULAR DIAGNOSTICS DEVICE TECHNOLOGIES, BY LEADING COMPANIES, 2015 (%)
    • FIGURE 42: GLOBAL MARKET SHARES OF NEEDLE-FREE DRUG DELIVERY TECHNOLOGIES, BY REGION, 2015 (%)
Back to Top